Clinical efficacy of arbekacin for Gram-negative bacteria

Abstract In an analysis of methicillin-resistant Staphylococcus aureus (MRSA) infected patients treated with arbekacin (ABK) only, Gram-negative bacteria (GNB) that were inhibited by low minimal inhibitory concentrations (MICs) of amikacin (AMK) or gentamycin (GM) were eradicated by the end of the A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2011-12, Vol.17 (6), p.876-879
Hauptverfasser:	Hamada, Yukihiro, Kuroyama, Masakazu, Tamura, Kazuyoshi, Yago, Kazuo, Koyama, Ikumi, Sunakawa, Keisuke
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Amikacin Anti-Bacterial Agents - therapeutic use Arbekacin Blood concentration level Coinfection - drug therapy Coinfection - microbiology Dibekacin - analogs & derivatives Dibekacin - therapeutic use Drug resistance Female Gram-negative bacteria Gram-negative bacteria (GNB) Gram-Negative Bacteria - drug effects Gram-Negative Bacteria - isolation & purification Gram-Negative Bacterial Infections - drug therapy Gram-Negative Bacterial Infections - microbiology Hematology, Oncology and Palliative Medicine Humans Infectious Diseases Male Medical Microbiology Medicine Medicine & Public Health Methicillin-Resistant Staphylococcus aureus - drug effects Microbial Sensitivity Tests Middle Aged Minimal inhibitory concentration (MIC) Minimum inhibitory concentration Mixed infection Staphylococcal Infections - drug therapy Staphylococcal Infections - microbiology Staphylococcus aureus Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!